FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Gerbing

Research Profile

Living Beings

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

fms-Like Tyrosine Kinase 3

Activities & Behaviors

Life Tables

Co-author Network

Publications

TOP 3
Lillian Sung; Todd A Alonzo; Richard Aplenc; Robert B Gerbing; Thomas Lehrnbecher; Alan S Gamis
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Leslie Mortland; Jessica A Pollard; Stanley Pounds; Susana Raimondi; Raul C Ribeiro; Jeffrey E Rubnitz; Roland B Walter; Todd A Alonzo; Xueyuan Cao; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy Hirsch; Michael R Loken; Soheil Meshinchi; Amit K Mitra; Jatinder Lamba
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy.
Michele S Redell; Marcos J Ruiz; David Tweardy; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; Soheil Meshinchi
FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Gerbing (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lillian Sung; Todd A Alonzo; Richard Aplenc; Robert B Gerbing; Thomas Lehrnbecher; Alan S Gamis
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Blood 2013;121(18):3573-7.
2013: Leslie Mortland; Jessica A Pollard; Stanley Pounds; Susana Raimondi; Raul C Ribeiro; Jeffrey E Rubnitz; Roland B Walter; Todd A Alonzo; Xueyuan Cao; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy Hirsch; Michael R Loken; Soheil Meshinchi; Amit K Mitra; Jatinder Lamba
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(6):1620-7.
2013: Michele S Redell; Marcos J Ruiz; David Tweardy; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; Soheil Meshinchi
FACS analysis of Stat3/5 signaling reveals sensitivity to G-CSF and IL-6 as a significant prognostic factor in pediatric AML: a Children's Oncology Group report.
Blood 2013;121(7):1083-93.
2013: Chelsea J Gudgeon; Kimberly H Harrington; Betsy A Hirsch; George S Laszlo; Soheil Meshinchi; Susana C Raimondi; Todd A Alonzo; Alan S Gamis; Robert B Gerbing; Roland B Walter
High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Leukemia & lymphoma 2013;54(1):202-4.
2012: Lillian Sung; Todd A Alonzo; Richard Aplenc; Alan S Gamis; Robert B Gerbing
Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group.
Haematologica 2012;97(11):1770-3.
2012: Andrzej Rochowski; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; Susan B Olson; BLANCHE ALTER
Patients with Fanconi anemia and AML have different cytogenetic clones than de novo cases of AML.
Pediatric blood & cancer 2012;59(5):922-4.
2012: April D Sorrell; Jeffrey W Taub; William G Woods; Todd A Alonzo; Robert J Arceci; Dorothy Barnard; Robert B Gerbing; Lois Hathaway; Joanne M Hilden; Thomas W Loew; Yaddanapudi Ravindranath; Franklin O Smith; Alan S Gamis
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Cancer 2012;118(19):4806-14.
2012: Michael R Loken; Laura Pardo; Susana C Raimondi; Todd A Alonzo; Todd M Cooper; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy A Hirsch; Phoenix Anh-Dung Ho; Soheil Meshinchi
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.
Blood 2012;120(8):1581-8.
2012: Richard Aplenc; David Bertoch; B T Fisher; Robert B Gerbing; M Hall; Y S Huang; R Keren; Y Li; A E Seif; L Sung; Peter Charles Adamson; Todd A Alonzo; Alan S Gamis
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.
Pharmacoepidemiology and drug safety 2012;21 Suppl 2():37-43.
2012: Jessica A Pollard; Susana C Raimondi; Roland B Walter; Todd A Alonzo; Irwin D Bernstein; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy Hirsch; Phoenix Anh-Dung Ho; Michael Loken; Soheil Meshinchi
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
Blood 2012;119(16):3705-11.
2012: Donna L Johnston; Beverly J Lange; Todd A Alonzo; Robert B Gerbing; William G Woods
Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
Pediatric blood & cancer 2012;58(4):519-24.
2012: Todd M Cooper; James Feusner; Janet Franklin; Todd A Alonzo; Robert J Arceci; Robert B Gerbing; Betsy Hirsch; Craig Hurwitz; Robert Iannone; Robert S Lavey; Prasad Mathew; Soheil Meshinchi; Susana C Raimondi; Franklin O Smith; Alan Gamis
AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Cancer 2012;118(3):761-9.
2011: Prasad Mathew; Susana C Raimondi; Franklin O Smith; Tanya Wallas; Todd A Alonzo; Cathy M Chavez; Nancy L Eisenberg; Alan Gamis; Robert B Gerbing; Jerald Z Gong; Betsy Hirsch; Rama Jasty; Dean T Jorstad; Robert J Arceci
A phase II study of amifostine in children with myelodysplastic syndrome: a report from the Children's Oncology Group study (AAML0121).
Pediatric blood & cancer 2011;57(7):1230-2.
2011: Phoenix Anh-Dung Ho; Craig A Hurwitz; Kenneth J Kopecky; Julia Kuhn; Todd A Alonzo; Jeanne E Anderson; Frederick R Appelbaum; Irwin D Bernstein; Janet L Franklin; Alan S Gamis; Robert B Gerbing; John E Godwin; Betsy A Hirsch; Kristen L Miller; Vivian G Oehler; Stephen H Petersdorf; Jerald P Radich; Susana C Raimondi; Gregory H Reaman; Rhonda E Ries; Derek L Stirewalt; Cheryl L Willman; Rong Zeng; Soheil Meshinchi
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Blood 2011;118(17):4561-6.
2011: Beverly J Lange; Eric L Sievers; Richard K Yang; Todd A Alonzo; Jacek Gan; Robert B Gerbing; Jaquelyn A Hank; Paul M Sondel
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Pediatric blood & cancer 2011;57(3):398-405.
2011: Phoenix Anh-Dung Ho; Jason Joaquin; Matthew A Kutny; Todd A Alonzo; Alan S Gamis; Robert B Gerbing; Susana C Raimondi; Soheil Meshinchi
Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.
Pediatric blood & cancer 2011;57(2):204-9.
2011: Martin A Champagne; Cecilia H Fu; Myron Chang; Helen Chen; Robert B Gerbing; Todd A Alonzo; Linda D Cooley; Nyla A Heerema; Vivian Oehler; Charlotte Wood; Mary Ellen French; Robert J Arceci; Franklin O Smith; Mark L Bernstein
Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: a report from the Children's Oncology Group.
Pediatric blood & cancer 2011;57(1):56-62.
2011: J N Berman; J L Franklin; Alan S Gamis; Robert B Gerbing; Nyla A Heerema; B Hirsch; Phoenix Anh-Dung Ho; C Hurwitz; B Lange; K Miller; Susana C Raimondi; Todd A Alonzo; Soheil Meshinchi
Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.
Leukemia 2011;25(6):1039-42.
2011: Michele S Redell; Marcos J Ruiz; Todd A Alonzo; Robert B Gerbing; David Tweardy
Stat3 signaling in acute myeloid leukemia: ligand-dependent and -independent activation and induction of apoptosis by a novel small-molecule Stat3 inhibitor.
Blood 2011;117(21):5701-9.
2011: Phoenix Anh-Dung Ho; Julia Kuhn; Robert B Gerbing; Jessica A Pollard; Rong Zeng; Kristen L Miller; Nyla A Heerema; Susana C Raimondi; Betsy A Hirsch; Janet L Franklin; Beverly Lange; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):704-11.
2010: Donna L Johnston; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; William G Woods
The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: a Children's Oncology Group study.
Pediatric blood & cancer 2010;55(3):414-20.
2010: Phoenix Anh-Dung Ho; Rong Zeng; Todd A Alonzo; Robert B Gerbing; Kristen L Miller; Jessica A Pollard; Derek L Stirewalt; Nyla A Heerema; Susana C Raimondi; Betsy Hirsch; Janet L Franklin; Beverly Lange; Soheil Meshinchi
Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood 2010;116(5):702-10.
2010: Christine L Phillips; Robert B Gerbing; Todd A Alonzo; John P Perentesis; Isaac T W Harley; Soheil Meshinchi; Deepika Bhatla; Gretchen Radloff; Stella M Davies
MDM2 polymorphism increases susceptibility to childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatric blood & cancer 2010;55(2):248-53.
2010: Roland B Walter; Todd A Alonzo; Robert B Gerbing; Phoenix Anh-Dung Ho; Franklin O Smith; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Janet L Franklin; Craig A Hurwitz; Michael R Loken; Soheil Meshinchi
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2831-8.
2010: Phoenix Anh-Dung Ho; Todd A Alonzo; Kenneth J Kopecky; K L Miller; J Kuhn; R Zeng; Robert B Gerbing; Susana C Raimondi; B A Hirsch; Vivian G Oehler; C A Hurwitz; J L Franklin; A S Gamis; Stephen H Petersdorf; Jeanne E Anderson; G H Reaman; Laurence H Baker; Cheryl L Willman; Irwin D Bernstein; Jerald P Radich; Frederick R Appelbaum; Derek L Stirewalt; Soheil Meshinchi
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
Leukemia 2010;24(5):909-13.
2010: Jessica A Pollard; Todd A Alonzo; Robert B Gerbing; Phoenix Anh-Dung Ho; Rong Zeng; Yaddanapudi Ravindranath; Gary Dahl; Norman J Lacayo; David Becton; Myron Chang; Howard J Weinstein; Betsy Hirsch; Susana C Raimondi; Nyla A Heerema; William G Woods; Beverly J Lange; Craig Hurwitz; Robert J Arceci; Jerald P Radich; Irwin D Bernstein; Michael C Heinrich; Soheil Meshinchi
Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML.
Blood 2010;115(12):2372-9.
2009: Suzie A Noronha; JASON FARRAR; Todd A Alonzo; Robert B Gerbing; Norman J Lacayo; Gary V Dahl; Yaddanapudi Ravindranath; Robert J Arceci; David M Loeb
WT1 expression at diagnosis does not predict survival in pediatric AML: a report from the Children's Oncology Group.
Pediatric blood & cancer 2009;53(6):1136-9.
2009: Phoenix Anh-Dung Ho; Todd A Alonzo; Robert B Gerbing; Jessica Pollard; Derek L Stirewalt; Craig Hurwitz; Nyla A Heerema; Betsy Hirsch; Susana C Raimondi; Beverly Lange; Janet L Franklin; Jerald P Radich; Soheil Meshinchi
Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Blood 2009;113(26):6558-66.
2009: Katherine K Matthay; Charles Patrick Reynolds; Robert C Seeger; Hiroyuki Shimada; E Stanton Adkins; Daphne A Haas-Kogan; Robert B Gerbing; Wendy B London; Judith G Villablanca
Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(7):1007-13.
2009: Deepika Bhatla; Robert B Gerbing; Todd A Alonzo; Heather Conner; Julie A Ross; Soheil Meshinchi; Xiaowen Zhai; Tiffany Zamzow; Parinda A Mehta; Hartmut Geiger; John P Perentesis; Stella M Davies
Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.
British journal of haematology 2009;144(3):388-94.
2009: Julie R Park; Judith G Villablanca; Wendy B London; Robert B Gerbing; Daphne Haas-Kogan; E Stanton Adkins; Edward F Attiyeh; John M Maris; Robert C Seeger; Charles Patrick Reynolds; Katherine K Matthay
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
Pediatric blood & cancer 2009;52(1):44-50.
2008: John T Horan; Todd A Alonzo; Gary H Lyman; Robert B Gerbing; Beverly J Lange; Yaddanapudi Ravindranath; David Becton; Franklin O Smith; William G Woods
Impact of disease risk on efficacy of matched related bone marrow transplantation for pediatric acute myeloid leukemia: the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5797-801.
2008: Parinda A Mehta; Robert B Gerbing; Todd A Alonzo; James S Elliott; Tiffany A Zamzow; Michelle Combs; Emily Stover; Julie A Ross; John P Perentesis; Soheil Meschinchi; Beverly J Lange; Stella M Davies
FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(23):7896-9.
2008: Lillian Sung; Todd A Alonzo; Robert B Gerbing; Richard Aplenc; Beverly J Lange; William G Woods; James Feusner; Janet Franklin; Maria J Patterson; Alan S Gamis
Respiratory syncytial virus infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.
Pediatric blood & cancer 2008;51(6):784-6.
2008: Soheil Meshinchi; Derek L Stirewalt; Todd A Alonzo; Titus Boggon; Robert B Gerbing; Jennifer L Rocnik; Beverly J Lange; D Gary Gilliland; Jerald P Radich
Structural and numerical variation of FLT3/ITD in pediatric AML.
Blood 2008;111(10):4930-3.
2008: Richard Aplenc; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; Craig A Hurwitz; Robert J Wells; Irwin D Bernstein; Patrick Buckley; Kathleen Krimmel; Franklin O Smith; Eric L Sievers; Robert J Arceci
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(14):2390-3295.
2008: D Bhatla; Robert B Gerbing; Todd A Alonzo; Parinda A Mehta; K Deal; J Elliott; Soheil Meshinchi; H Geiger; John P Perentesis; Beverly J Lange; Stella M Davies
DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.
Leukemia 2008;22(2):265-72.
2008: Beverly J Lange; Franklin O Smith; James Feusner; Dorothy R Barnard; Patricia A Dinndorf; Stephen Feig; Nyla A Heerema; Carola Arndt; Robert J Arceci; Nita L Seibel; Margie Weiman; Kathryn E Dusenbery; Kevin Shannon; Sandra Luna-Fineman; Robert B Gerbing; Todd A Alonzo
Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.
Blood 2008;111(3):1044-53.
2007: Lillian Sung; Beverly J Lange; Robert B Gerbing; Todd A Alonzo; James Feusner
Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.
Blood 2007;110(10):3532-9.
2007: Dorothy R Barnard; Todd A Alonzo; Robert B Gerbing; Beverly Lange; William G Woods
Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Pediatric blood & cancer 2007;49(1):17-22.
2007: Draga Barbaric; Todd A Alonzo; Robert B Gerbing; Soheil Meshinchi; Nyla A Heerema; Dorothy R Barnard; Beverly J Lange; William G Woods; Robert J Arceci; Franklin O Smith
Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
Blood 2007;109(6):2314-21.
2006: Soheil Meshinchi; Todd A Alonzo; Derek L Stirewalt; Michel Zwaan; Martin Zimmerman; Dirk Reinhardt; G J L Kaspers; Nyla A Heerema; Robert B Gerbing; Beverly J Lange; Jerald P Radich
Clinical implications of FLT3 mutations in pediatric AML.
Blood 2006;108(12):3654-61.
2006: Jessica A Pollard; Todd A Alonzo; Robert B Gerbing; William G Woods; Beverly J Lange; David A Sweetser; Jerald P Radich; Irwin D Bernstein; Soheil Meshinchi
FLT3 internal tandem duplication in CD34+/CD33- precursors predicts poor outcome in acute myeloid leukemia.
Blood 2006;108(8):2764-9.
2006: Richard Aplenc; Todd A Alonzo; Robert B Gerbing; Franklin O Smith; Soheil Meshinchi; Julie A Ross; John P Perentesis; William G Woods; Beverly J Lange; Stella M Davies
Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group.
Blood 2006;108(1):74-80.
2006: Hideki Sano; Jeffrey Bonadio; Robert B Gerbing; Wendy B London; Katherine K Matthay; John N Lukens; Hiroyuki Shimada
International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
European journal of cancer (Oxford, England : 1990) 2006;42(8):1113-9.
2006: Parinda A Mehta; Todd A Alonzo; Robert B Gerbing; James S Elliott; Tiffany A Wilke; Rebekah J Kennedy; Julie A Ross; John P Perentesis; Beverly J Lange; Stella M Davies
XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report.
Blood 2006;107(1):39-45.
2005: Donna L Johnston; Todd A Alonzo; Robert B Gerbing; Beverly J Lange; William G Woods
Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9172-8.
2005: F O Smith; Todd A Alonzo; Robert B Gerbing; William G Woods; Robert J Arceci
Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
Leukemia 2005;19(12):2054-62.
2005: Mary Lou Schmidt; Ashutosh Lal; Robert C Seeger; John M Maris; Hiroyuki Shimada; Maura O'Leary; Robert B Gerbing; Katherine K Matthay
Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6474-80.
2005: Todd A Alonzo; Robert J Wells; William G Woods; B Lange; Robert B Gerbing; Allen B Buxton; Steven Neudorf; J Sanders; F O Smith; S A Feig
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.
Leukemia 2005;19(6):965-70.
2005: Beverly J Lange; Robert B Gerbing; James Feusner; Jeffrey Skolnik; Nancy Sacks; Franklin O Smith; Todd A Alonzo
Mortality in overweight and underweight children with acute myeloid leukemia.
JAMA : the journal of the American Medical Association 2005;293(2):203-11.
2005: Chie Kobayashi; Hector L Monforte-Munoz; Robert B Gerbing; Daniel O Stram; Katherine K Matthay; John N Lukens; Robert C Seeger; Hiroyuki Shimada
Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Cancer 2005;103(1):174-80.
2004: William Tse; Soheil Meshinchi; Todd A Alonzo; Derek L Stirewalt; Robert B Gerbing; William G Woods; Frederick R Appelbaum; Jerald P Radich
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
Blood 2004;104(10):3058-63.
2004: Mignon L Loh; Melissa G Reynolds; Shashaank Vattikuti; Robert B Gerbing; Todd A Alonzo; Elaine Carlson; J W Cheng; Connie M Lee; Beverly J Lange; Soheil Meshinchi
PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
Leukemia 2004;18(11):1831-4.
2004: Patrick Brown; Soheil Meshinchi; Mark Levis; Todd A Alonzo; Robert B Gerbing; Beverly Lange; Robert J Arceci; Donald Small
Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition.
Blood 2004;104(6):1841-9.
2004: E Stanton Adkins; Robert Sawin; Robert B Gerbing; Wendy B London; Katherine K Matthay; Gerald M Haase
Efficacy of complete resection for high-risk neuroblastoma: a Children's Cancer Group study.
Journal of pediatric surgery 2004;39(6):931-6.
2004: Beverly J Lange; Patricia A Dinndorf; Franklin O Smith; Carola Arndt; Dorothy Barnard; Stephen Feig; James Feusner; Nita L Seibel; Margie Weiman; Richard Aplenc; Robert B Gerbing; Todd A Alonzo
Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):150-6.
2003: Michel Peuchmaur; Emanuele S G d'Amore; Vijay V Joshi; Jun-ichi Hata; Borghild Roald; Louis P Dehner; Robert B Gerbing; Daniel O Stram; John N Lukens; Katherine K Matthay; Hiroyuki Shimada
Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
Cancer 2003;98(10):2274-81.
2003: Daphne A Haas-Kogan; Patrick S Swift; Michael T Selch; Gerald M Haase; Robert C Seeger; Robert B Gerbing; Daniel O Stram; Katherine K Matthay
Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study.
International journal of radiation oncology, biology, physics 2003;56(1):28-39.
2003: Eric L Sievers; Beverly J Lange; Todd A Alonzo; Robert B Gerbing; Irwin D Bernstein; Franklin O Smith; Robert J Arceci; William G Woods; Michael R Loken
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.
Blood 2003;101(9):3398-406.
2001: S Goto; S Umehara; Robert B Gerbing; Daniel O Stram; Garrett M Brodeur; Robert C Seeger; John N Lukens; Katherine K Matthay; Hiroyuki Shimada
Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Cancer 2001;92(10):2699-708.
2001: Hiroyuki Shimada; S Umehara; Y Monobe; Y Hachitanda; Atsuko Nakagawa; S Goto; Robert B Gerbing; Daniel O Stram; John N Lukens; Katherine K Matthay
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Cancer 2001;92(9):2451-61.
2001: R Cooper; Yasmin Khakoo; Katherine K Matthay; John N Lukens; Robert C Seeger; Daniel O Stram; Robert B Gerbing; Atsuko Nakagawa; H Shimada
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group.
Medical and pediatric oncology 2001;36(6):623-9.
2001: Emily F Rudnick; Yasmin Khakoo; Nuno Lobo Antunes; Robert C Seeger; G M Brodeur; H Shimada; Robert B Gerbing; Daniel O Stram; Katherine K Matthay
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Medical and pediatric oncology 2001;36(6):612-22.
2001: John M Maris; Chun Guo; D Blake; Peter White; Michael D Hogarty; Patricia M Thompson; V Rajalingam; Robert B Gerbing; DO Stram; KK Matthay; Robert C Seeger; Garrett M Brodeur
Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Medical and pediatric oncology 2001;36(1):32-6.
2001: Patricia M Thompson; BA Seifried; S K Kyemba; SJ Jensen; Chun Guo; John M Maris; Garrett M Brodeur; DO Stram; Robert C Seeger; Robert B Gerbing; KK Matthay; Tara C Matise; Peter White
Loss of heterozygosity for chromosome 14q in neuroblastoma.
Medical and pediatric oncology 2001;36(1):28-31.
2001: John M Maris; Chun Guo; Peter White; Michael D Hogarty; Patricia M Thompson; DO Stram; Robert B Gerbing; KK Matthay; Robert C Seeger; Garrett M Brodeur
Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.
Medical and pediatric oncology 2001;36(1):24-7.
2000: Robert C Seeger; Charles Patrick Reynolds; R Gallego; Daniel O Stram; Robert B Gerbing; Katherine K Matthay
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(24):4067-76.
2000: L M Choi; Nam W Kim; JJ Zuo; Robert B Gerbing; Daniel O Stram; John N Lukens; Katherine K Matthay; Robert C Seeger; Charles Patrick Reynolds
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma.
Medical and pediatric oncology 2000;35(6):647-50.
2000: H Goto; Nino Keshelava; Katherine K Matthay; John N Lukens; Robert B Gerbing; Daniel O Stram; Robert C Seeger; Charles Patrick Reynolds
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors.
Medical and pediatric oncology 2000;35(6):619-22.
2000: Chun Guo; Peter White; Michael D Hogarty; Garrett M Brodeur; Robert B Gerbing; Daniel O Stram; John M Maris
Deletion of 11q23 is a frequent event in the evolution of MYCN single-copy high-risk neuroblastomas.
Medical and pediatric oncology 2000;35(6):544-6.
2000: S Umehara; Atsuko Nakagawa; Katherine K Matthay; John N Lukens; Robert C Seeger; Daniel O Stram; Robert B Gerbing; Hiroyuki Shimada
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
Cancer 2000;89(5):1150-61.
2000: John M Maris; Mitchell J Weiss; Chun Guo; Robert B Gerbing; Daniel O Stram; Peter White; Michael D Hogarty; Erik P Sulman; Patricia M Thompson; John N Lukens; Katherine K Matthay; Robert C Seeger; Garrett M Brodeur
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1888-99.
2000: Mary Lou Schmidt; John N Lukens; Robert C Seeger; Garrett M Brodeur; Hiroyuki Shimada; Robert B Gerbing; Daniel O Stram; C Perez; Gerald M Haase; Katherine K Matthay
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(6):1260-8.
2000: H James Nickerson; Katherine K Matthay; Robert C Seeger; Garrett M Brodeur; H Shimada; C Perez; JB Atkinson; Michael T Selch; Robert B Gerbing; Daniel O Stram; John N Lukens
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):477-86.
2000: C A Perez; Katherine K Matthay; JB Atkinson; Robert C Seeger; Hiroyuki Shimada; Gerald M Haase; Daniel O Stram; Robert B Gerbing; John N Lukens
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(1):18-26.
1999: Katherine K Matthay; Judith G Villablanca; Robert C Seeger; Daniel O Stram; R E Harris; N K Ramsay; Patrick S Swift; Hiroyuki Shimada; CT Black; Garrett M Brodeur; Robert B Gerbing; Charles Patrick Reynolds
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.
The New England journal of medicine 1999;341(16):1165-73.
1999: Chun Guo; Peter White; Mitchell J Weiss; Michael D Hogarty; Patricia M Thompson; DO Stram; Robert B Gerbing; KK Matthay; Robert C Seeger; Garrett M Brodeur; John M Maris
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
Oncogene 1999;18(35):4948-57.
1999: Hiroyuki Shimada; Inge M Ambros; Louis P Dehner; Jun-ichi Hata; Vijay V Joshi; Borghild Roald; Daniel O Stram; Robert B Gerbing; John N Lukens; Katherine K Matthay; Robert P Castleberry
The International Neuroblastoma Pathology Classification (the Shimada system).
Cancer 1999;86(2):364-72.
1999: S G DuBois; Y Kalika; John N Lukens; Garrett M Brodeur; Robert C Seeger; JB Atkinson; Gerald M Haase; CT Black; C Perez; Hiroyuki Shimada; Robert B Gerbing; Daniel O Stram; Katherine K Matthay
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.
Journal of pediatric hematology/oncology 1999;21(3):181-9.
1998: Katherine K Matthay; C Perez; Robert C Seeger; Garrett M Brodeur; Hiroyuki Shimada; JB Atkinson; CT Black; Robert B Gerbing; Gerald M Haase; Daniel O Stram; Patrick S Swift; John N Lukens
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1256-64.